Literature DB >> 15030511

Reduced ratio of protective versus proinflammatory cytokine responses to commensal bacteria in HLA-B27 transgenic rats.

L A Dieleman1, F Hoentjen, B-F Qian, D Sprengers, E Tjwa, M F Torres, C D Torrice, R B Sartor, S L Tonkonogy.   

Abstract

Germ-free HLA-B27 transgenic (TG) rats do not develop colitis, but colonization with specific pathogen-free (SPF) bacteria induces colitis accompanied by immune activation. To study host-dependent immune responses to commensal caecal bacteria we investigated cytokine profiles in mesenteric lymph node (MLN) cells from HLA-B27 TG versus nontransgenic (non-TG) littermates after in vitro stimulation with caecal bacterial lysates (CBL). Supernatants from CBL-stimulated unseparated T- or B- cell-depleted MLN cells from HLA-B27 TG and non-TG littermates were analysed for IFN-gamma, IL-12, TNF, IL-10 and TGF-beta production. Our results show that unfractionated TG MLN cells stimulated with CBL produced more IFN-gamma, IL-12 and TNF than did non-TG MLN cells. In contrast, CBL-stimulated non-TG MLN cells produced more IL-10 and TGF-beta. T cell depletion abolished IFN-gamma and decreased IL-12 production, but did not affect IL-10 and TGF-beta production. Conversely, neither IL-10 nor TGF-beta was produced in cultures of B cell-depleted MLN. In addition, CD4(+) T cells enriched from MLN of HLA-B27 TG but not from non-TG rats produced IFN-gamma when cocultured with CBL-pulsed antigen presenting cells from non-TG rats. Interestingly, IL-10 and TGF-beta, but not IFN-gamma, IL-12 and TNF were produced by MLN cells from germ-free TG rats. These results indicate that the colitis that develops in SPF HLA-B27 TG rats is accompanied by activation of IFN-gamma-producing CD4(+) T cells that respond to commensal bacteria. However, B cell cytokine production in response to components of commensal intestinal microorganisms occurs in the absence of intestinal inflammation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15030511      PMCID: PMC1808999          DOI: 10.1111/j.1365-2249.2004.02410.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  50 in total

Review 1.  The role of HLA-B27 in spondyloarthritis.

Authors:  R L Allen; P Bowness; A McMichael
Journal:  Immunogenetics       Date:  1999-11       Impact factor: 2.846

2.  Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice.

Authors:  K L Madsen; J S Doyle; M M Tavernini; L D Jewell; R P Rennie; R N Fedorak
Journal:  Gastroenterology       Date:  2000-06       Impact factor: 22.682

3.  MHC-II-independent CD4+ T cells induce colitis in immunodeficient RAG-/- hosts.

Authors:  Z Trobonjaca; F Leithäuser; P Möller; H Bluethmann; Y Koezuka; H R MacDonald; J Reimann
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

Review 4.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

5.  Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

Authors:  L Steidler; W Hans; L Schotte; S Neirynck; F Obermeier; W Falk; W Fiers; E Remaut
Journal:  Science       Date:  2000-08-25       Impact factor: 47.728

6.  Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group.

Authors:  S Schreiber; R N Fedorak; O H Nielsen; G Wild; C N Williams; S Nikolaus; M Jacyna; B A Lashner; A Gangl; P Rutgeerts; K Isaacs; S J van Deventer; J C Koningsberger; M Cohard; A LeBeaut; S B Hanauer
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

7.  Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice.

Authors:  H C Rath; M Schultz; R Freitag; L A Dieleman; F Li; H J Linde; J Schölmerich; R B Sartor
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

8.  Treatment of experimental (Trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-beta1 plasmid: TGF-beta1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor beta2 chain downregulation.

Authors:  A Kitani; I J Fuss; K Nakamura; O M Schwartz; T Usui; W Strober
Journal:  J Exp Med       Date:  2000-07-03       Impact factor: 14.307

9.  An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation.

Authors:  C Asseman; S Mauze; M W Leach; R L Coffman; F Powrie
Journal:  J Exp Med       Date:  1999-10-04       Impact factor: 14.307

10.  B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation.

Authors:  V Moulin; F Andris; K Thielemans; C Maliszewski; J Urbain; M Moser
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

View more
  16 in total

Review 1.  The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.

Authors:  Helena Tlaskalová-Hogenová; Renata Stěpánková; Hana Kozáková; Tomáš Hudcovic; Luca Vannucci; Ludmila Tučková; Pavel Rossmann; Tomáš Hrnčíř; Miloslav Kverka; Zuzana Zákostelská; Klára Klimešová; Jaroslava Přibylová; Jiřina Bártová; Daniel Sanchez; Petra Fundová; Dana Borovská; Dagmar Srůtková; Zdeněk Zídek; Martin Schwarzer; Pavel Drastich; David P Funda
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 2.  Probiotics and prebiotics in chronic inflammatory bowel diseases.

Authors:  Julia B Ewaschuk; Levinus A Dieleman
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

3.  Adoptive transfer of nontransgenic mesenteric lymph node cells induces colitis in athymic HLA-B27 transgenic nude rats.

Authors:  F Hoentjen; S L Tonkonogy; B Liu; R B Sartor; J D Taurog; L A Dieleman
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

4.  Endogenous antigen presenting cell-derived IL-10 inhibits T lymphocyte responses to commensal enteric bacteria.

Authors:  Carol A Albright; R Balfour Sartor; Susan L Tonkonogy
Journal:  Immunol Lett       Date:  2009-03-03       Impact factor: 3.685

5.  Intravenous injection of endogenous microbial components abrogates DSS-induced colitis.

Authors:  Beate C Sydora; Eric J Albert; Rae R Foshaug; Jason S G Doyle; Thomas A Churchill; Richard N Fedorak
Journal:  Dig Dis Sci       Date:  2011-09-01       Impact factor: 3.199

6.  An imbalance in mucosal cytokine profile causes transient intestinal inflammation following an animal's first exposure to faecal bacteria and antigens.

Authors:  B C Sydora; S M MacFarlane; M Lupicki; A L Dmytrash; L A Dieleman; R N Fedorak
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

Review 7.  Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics.

Authors:  Nina A Hering; Michael Fromm; Jörg-Dieter Schulzke
Journal:  J Physiol       Date:  2012-01-04       Impact factor: 5.182

8.  Helicobacter bilis triggers persistent immune reactivity to antigens derived from the commensal bacteria in gnotobiotic C3H/HeN mice.

Authors:  Albert E Jergens; Jennifer H Wilson-Welder; Andrea Dorn; Abigail Henderson; Zhiping Liu; Richard B Evans; Jesse Hostetter; Michael J Wannemuehler
Journal:  Gut       Date:  2006-12-04       Impact factor: 23.059

9.  Dysregulated luminal bacterial antigen-specific T-cell responses and antigen-presenting cell function in HLA-B27 transgenic rats with chronic colitis.

Authors:  Bi-Feng Qian; Susan L Tonkonogy; Frank Hoentjen; Levinus A Dieleman; R Balfour Sartor
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

10.  Luminal bacterial antigen-specific CD4+ T-cell responses in HLA-B27 transgenic rats with chronic colitis are mediated by both major histocompatibility class II and HLA-B27 molecules.

Authors:  Bi-Feng Qian; Susan L Tonkonogy; R Balfour Sartor
Journal:  Immunology       Date:  2006-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.